Prevalence and Predictors of Complications of Radiofrequency Catheter Ablation for Atrial Fibrillation

• Published in: Journal of cardiovascular electrophysiology Vol. 22; no. 6; pp. 626 - 631
• Main Authors: BAMAN, TIMIR S., JONGNARANGSIN, KRIT, CHUGH, AMAN, SUWANAGOOL, ARISARA, GUIOT, AURELIE, MADENCI, ARIN, WALSH, SPENCER, ILG, KARL J., GUPTA, SANJAYA K., LATCHAMSETTY, RAKESH, BAGWE, SUVEER, MYLES, JAMES D., CRAWFORD, THOMAS, GOOD, ERIC, BOGUN, FRANK, PELOSI, JR, FRANK, MORADY, FRED, ORAL, HAKAN
• Format: Journal Article
• Language: English
• Published: Malden, USA Blackwell Publishing Inc 01.06.2011
• Subjects: atrial fibrillation; Atrial Fibrillation - epidemiology; Atrial Fibrillation - surgery; catheter ablation; Catheter Ablation - statistics & numerical data; complications; Female; Germany - epidemiology; Humans; Male; Middle Aged; Postoperative Complications - epidemiology; Prevalence; pulmonary vein stenosis; Risk Assessment; Risk Factors; stroke; Germany
• ISSN: 1045-3873; 1540-8167; 1540-8167
• DOI: 10.1111/j.1540-8167.2010.01995.x

Complications of Atrial Fibrillation Ablation. Introduction: Up to 6% of patients experience complications after radiofrequency catheter ablation (RFA) of atrial fibrillation (AF). The purpose of this study is to determine the prevalence and predictors of periprocedural complications after RFA for AF. Methods and Results: The subjects were 1,295 consecutive patients (age = 60 ± 10 years) who underwent RFA (n = 1,642) for paroxysmal (53%) or persistent AF (47%) from January 2007 to January 2010. A complication occurred in 57 patients (3.5%); a vascular access complication in 31 (1.9%); pericardial tamponade in 20 (1.2%); a thromboembolic event in 4 (0.2%); deep venous thrombosis in 1 (<0.01%); and pulmonary vein stenosis in 1 patient (<0.01%). There were no procedure‐related deaths. On multivariate analysis, female gender (OR = 2.27; ±95% CI: 1.31–2.57, P < 0.01) and procedures performed in July or August (OR = 2.10; ±95% CI: 1.16–3.80, P = 0.01) were independent predictors of any complication. For vascular complications, treatment with clopidogrel (OR = 4.40; ±95% CI: 1.43–13.53, P = 0.01), female gender (OR = 3.65; ±95% CI: 1.72–7.75, P < 0.01) and performing RFA in July or August (OR = 2.71; ±95% CI: 1.25–5.87, P = 0.01) were independent predictors. The only predictor of cardiac tamponade was prior RFA (OR = 3.32; ±95% CI: 0.95–11.61; P < 0.05). Conclusion: Prevalence of perioperative complications for RFA of AF is 3.5% and vascular access complications constitute the majority. The need for clopidogrel therapy should be carefully considered prior to RFA. At teaching institutions close supervision should be exercised during vascular access early in the year. Improvements in ablation technology and elimination of the need for repeat procedures may decrease the risk of pericardial tamponade. (J Cardiovasc Electrophysiol, Vol. 22, pp. 626‐631, June 2011)